🇺🇸 Intravenous Paricalcitol in United States

Intravenous Paricalcitol (Intravenous Paricalcitol) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intravenous Paricalcitol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intravenous Paricalcitol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intravenous Paricalcitol in United States?

The University of Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.